Bone Biologics Corp (BBLGW) Return on Invested Capital (2014 - 2018)

Bone Biologics (BBLGW) has reported Return on Invested Capital for 5 consecutive years, with 0.0% the latest figure, recorded in Q2 2018.

• In Q2 2018, Return on Invested Capital changed 0.0% year-over-year to 0.0%; the TTM figure through Jun 2018 stood at 0.0% (changed 0.0% YoY), while the FY2014 annual figure was 0.01%, changed N/A from the prior year.
• Return on Invested Capital fell to 0.0% in Q2 2018 per BBLGW's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.0% in Q1 2014 and bottomed at 0.03% in Q1 2016.
• Historically, Return on Invested Capital has averaged 0.01% across 5 years, with a median of 0.0% in 2014.
• Annual changes were most pronounced in 2016 — Return on Invested Capital declined 3 bps — and 2017, when it rose 2 bps.
• Bone Biologics' Return on Invested Capital stood at 0.0% in 2014, then plunged by 473 bps to 0.02% in 2015, then jumped by 65 bps to 0.01% in 2016, then jumped by 91 bps to 0.0% in 2017, then slumped by 234 bps to 0.0% in 2018.
• Business Quant data shows BBLGW's Return on Invested Capital at 0.0% in Q2 2018, 0.0% in Q4 2017, and 0.0% in Q3 2017.